person · Reporting owner
Linthwaite Stephen Christopher
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STANDARD BIOTOOLS INC.FLDM · Entity 6116 | President & CEO | February 22, 2022 | February 24, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STANDARD BIOTOOLS INC.
Report date February 22, 2022 · Filed February 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 326,334 |
Reported balance
After 2022-02-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-02-22 · Exercise / conversion · Acquired 7,813 · Balance 326,334 F1: Includes 3,297 shares purchased on November 30, 2021 under the Company's 2017 Employee Stock Purchase Plan. |
| Common StockSEC Table I · non-derivative | Direct | 333,216 |
Reported balance
After 2022-02-22 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2022-02-22 · Exercise / conversion · Acquired 6,882 · Balance 333,216 |
| Common StockSEC Table I · non-derivative | Direct | 340,938 |
Reported balance
After 2022-02-22 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2022-02-22 · Exercise / conversion · Acquired 7,722 · Balance 340,938 |
| Common StockSEC Table I · non-derivative | Direct | 328,473 |
Reported balance
After 2022-02-22 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2022-02-22 · Tax withholding · Disposed 12,465 · Balance 328,473 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,813 |
Reported balance
After 2022-02-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-02-22 · Exercise / conversion · Disposed 7,813 · Balance 7,813 F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 27,528 |
Reported balance
After 2022-02-22 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-02-22 · Exercise / conversion · Disposed 6,882 · Balance 27,528 F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 61,779 |
Reported balance
After 2022-02-22 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-02-22 · Exercise / conversion · Disposed 7,722 · Balance 61,779 F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F5: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 3,297 shares purchased on November 30, 2021 under the Company's 2017 Employee Stock Purchase Plan.
F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.
F3: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter.
F4: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.
F5: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2018 Filed Aug 22, 2018 21:00 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000096 · wf-form4_153497164208170.xml · derivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,917 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F2 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:00 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 4,345 | $6.74 | $29,285.30 |
DisclosureSEC source: 0001162194-18-000096 · wf-form4_153497164208170.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,088 Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:00 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000096 · wf-form4_153497164208170.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,433 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:00 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000096 · wf-form4_153497164208170.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Jun 14, 2018 00:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000084 · wf-form4_152893780764698.xml · derivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to Reporting Person's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F3 · derivative.expiration_date: 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to Reporting Person's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
| May 20, 2018 Filed May 23, 2018 01:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000063 · wf-form4_152703733786689.xml · derivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,667 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| May 20, 2018 Filed May 23, 2018 01:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 1,643 | $5.73 | $9,414.39 |
DisclosureSEC source: 0001162194-18-000063 · wf-form4_152703733786689.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,871 Read SEC document |
| May 20, 2018 Filed May 23, 2018 01:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000063 · wf-form4_152703733786689.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2018 Filed Mar 22, 2018 01:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 95,500 | $0.00 Strike: $6.33 | $0.00 |
DisclosureSEC source: 0001162194-18-000037 · wf-form4_152168054679390.xml · derivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,500 Underlying: Common Stock · 95,500 shares Expires 2028-03-19 F1 · derivative.exercise_date: 12/48th of the total number of shares subject to the Option will vest on March 19, 2019 and 1/48th of the total shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that the Option will be fully vested on March 19, 2022, subject to the recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through each applicable vest date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000025 · wf-form4_151933514520546.xml · derivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,417 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F3 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 1,938 | $7.81 | $15,135.78 |
DisclosureSEC source: 0001162194-18-000025 · wf-form4_151933514520546.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,764 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000025 · wf-form4_151933514520546.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,047 shares purchased on November 30, 2017 under the Company's 2017 Employee Stock Purchase Plan. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000170 · wf-form4_151140249643249.xml · derivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,167 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 1,786 | $5.19 | $9,269.34 |
DisclosureSEC source: 0001162194-17-000170 · wf-form4_151140249643249.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,905 Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000170 · wf-form4_151140249643249.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 70,000 | Not disclosed Strike: $5.13 | Not disclosed |
DisclosureSEC source: 0001162194-17-000143 · wf-form4_150612935504039.xml · derivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2027-09-20 F2 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 140,000 shares of FLDM common stock granted to the Reporting Person on August 9, 2016. In exchange, the Reporting Person received a replacement Option, for 70,000 shares, having an exercise price of $5.13 per share. F3 · derivative.exercise_date: 1/12th of the total number of shares underlying the Option will vest on February 20, 2018, and 1/12th of the total number of shares underlying the Option granted will vest every three months thereafter until fully vested, subject to the Reporting Person's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 140,000 | Not disclosed Strike: $9.05 | Not disclosed |
DisclosureSEC source: 0001162194-17-000143 · wf-form4_150612935504039.xml · derivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 140,000 shares Expires 2026-08-09 F2 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 140,000 shares of FLDM common stock granted to the Reporting Person on August 9, 2016. In exchange, the Reporting Person received a replacement Option, for 70,000 shares, having an exercise price of $5.13 per share. F1 · derivative.exercise_date: The Option provided for vesting of 12/48th of the total number of shares subject to the Option on August 1, 2017 and thirty-six equal monthly installments beginning on September 1, 2017. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:07 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000123 · wf-form4_150352242166506.xml · derivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,917 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:07 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 1,786 | $3.76 | $6,715.36 |
DisclosureSEC source: 0001162194-17-000123 · wf-form4_150352242166506.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,941 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 21:07 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000123 · wf-form4_150352242166506.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 00:35 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | PurchaseCommon Stock | 45,000 | $2.66 | $119,884.50 |
DisclosureSEC source: 0001162194-17-000099 · wf-form4_150223892986672.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,977 F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $2.58 to $2.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document |
| May 22, 2017 Filed May 23, 2017 22:59 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 6,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000058 · wf-form4_149558036580130.xml · derivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,667 Underlying: Common Stock · 6,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| May 22, 2017 Filed May 23, 2017 22:59 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 2,356 | $5.46 | $12,863.76 |
DisclosureSEC source: 0001162194-17-000058 · wf-form4_149558036580130.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,977 Read SEC document |
| May 22, 2017 Filed May 23, 2017 22:59 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 6,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000058 · wf-form4_149558036580130.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:18 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 189,500 | $0.00 Strike: $6.16 | $0.00 |
DisclosureSEC source: 0001162194-17-000016 · wf-form4_148719710531829.xml · derivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,500 Underlying: Common Stock · 189,500 shares Expires 2027-02-13 F3 · derivative.exercise_date: 1/48th of the total number of shares subject to the option will vest each month after the Vesting Commencement Date, on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that the option will be fully vested on January 1, 2021, subject to recipient continuing to be a Service Provider (as defined in the Fluidigm Corporation 2011 Equity Incentive Plan) through each such date. "Vesting Commencement Date" shall mean January 1, 2017. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 22:18 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 76,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000016 · wf-form4_148719710531829.xml · derivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,000 Underlying: Common Stock · 76,000 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: 4/48th of the total number of shares underlying the Restricted Stock Units granted will vest on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F2 · derivative.expiration_date: 4/48th of the total number of shares underlying the Restricted Stock Units granted will vest on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 21:19 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | PurchaseCommon Stock | 55,000 | $6.36 | $350,064.00 |
DisclosureSEC source: 0001162194-16-000260 · wf-form4_148071352934829.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,000 F1 · shares: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $6.17 to $6.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $6.17 to $6.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 20:30 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001162194-16-000250 · wf-form4_147880971032193.xml · derivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2026-11-08 F1 · derivative.exercise_date: 12/48th of the total number of shares subject to the Option will vest and become exercisable on October 19, 2017 and 1/48th of the total number of shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that all shares subject to the Option will be fully vested and exercisable on October 19, 2020, subject to the recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through each applicable vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.